Logo image
Sign in
Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1c) without causing weight gain or increased hypoglycaemia
Journal article   Peer reviewed

Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1c) without causing weight gain or increased hypoglycaemia

J. Rosenstock, Marc S. Rendell, J. L. Gross, P. R. Fleck, C. A. Wilson and Q. Mekki
Diabetes, Obesity & Metabolism, Vol.11(12), pp.1145-1152
12/2009

Metrics

6 Record Views

Details